Concordia Healthcare Corp (TSE:CXR)‘s stock had its “outperform” rating reissued by investment analysts at Royal Bank Of Canada in a research report issued on Tuesday, reports. They presently have a C$18.50 target price on the stock. Royal Bank Of Canada’s price target suggests a potential upside of 206.29% from the company’s previous close.

Other research analysts have also recently issued research reports about the stock. Goldman Sachs Group Inc. dropped their target price on shares of Concordia Healthcare Corp from C$34.00 to C$17.00 in a report on Monday, August 15th. TD Securities dropped their target price on shares of Concordia Healthcare Corp from C$45.00 to C$37.00 and set a “buy” rating for the company in a report on Tuesday, June 28th. Finally, CIBC cut shares of Concordia Healthcare Corp from a “sector perform” rating to an “underperform” rating in a report on Monday, August 15th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of C$27.38.

Analyst Recommendations for Concordia Healthcare Corp (TSE:CXR)

Concordia Healthcare Corp (TSE:CXR) traded down 3.31% on Tuesday, hitting $5.84. 195,885 shares of the stock traded hands. The stock has a 50-day moving average price of $8.59 and a 200 day moving average price of $24.67. Concordia Healthcare Corp has a 1-year low of $5.80 and a 1-year high of $58.75. The company’s market cap is $297.94 million.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Concordia Healthcare Corp Company Profile

Stock Target Prices

Receive News & Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related companies with's FREE daily email newsletter.